Review
Sep 2026
Beyond the Generic Tumor: Engineering Patient-Specific Immune Ecosystems for Cancer.
Current evidence supports personalized immunotherapy as a promising approach for improving the precision of cancer treatment, but its clinical application remains constrained by biological, technical, manufacturing, regulatory, and clinical challenges.
Samira Anvari, Jalal Naghinezhad, Reza Farokhi et al.
· Critical reviews in oncology... · 0 citations